Alan L. Fuchsberg
Director/Board Member at ARMGO Pharma, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eugene Marcantonio | M | - |
ARMGO Pharma, Inc.
 ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | 7 years |
| Andrew R. Marks | M | - |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | 20 years |
| Anthony Welters | M | 69 |
New York University School of Law
| - |
| Karen L. Katen | F | 75 |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | - |
| Gerald Rosenfeld | M | 77 |
New York University School of Law
| - |
| David Tanner | M | 65 |
New York University School of Law
| - |
| Yael Webb | M | - |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | - |
| Vincent Tese | M | 81 |
New York University School of Law
| 34 years |
| Paul Gideon van Zyl | M | 55 |
New York University School of Law
| - |
| Kathryn Sudol | F | 49 |
New York University School of Law
| - |
| Benedict Kingsbury | M | - |
New York University School of Law
| - |
| Mitra O'Neill | F | 55 |
New York University School of Law
| - |
| Stewart Pollock | M | - |
New York University School of Law
| - |
| Peter Sudler | M | - |
New York University School of Law
| - |
| Mimi Marziani | F | - |
New York University School of Law
| - |
| Jennifer Arlen | F | - |
New York University School of Law
| - |
| Murray Bring | M | - |
New York University School of Law
| - |
| Sandro Belvedere | M | - |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | 18 years |
| Steven Tuttleman | M | - |
New York University School of Law
| 4 years |
| Kathi Larson | F | - |
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | 18 years |
| Scott Hoffman | M | 61 |
New York University School of Law
| - |
| Rachel Robbins | F | 73 |
New York University School of Law
| - |
| Tom Shropshire | M | - |
New York University School of Law
| - |
| John Suydam | M | 64 |
New York University School of Law
| - |
| Vijaya Gadde | F | 49 |
New York University School of Law
| - |
| Jeff Aronson | M | 66 |
New York University School of Law
| - |
| Roger Meltzer | M | 73 |
New York University School of Law
| 13 years |
| Richard Reiss | M | 80 |
New York University School of Law
| - |
| Mitchell Jacobson | M | 73 |
New York University School of Law
| - |
| Trevor Morrison | M | 53 |
New York University School of Law
| 11 years |
| Dean Garfield | M | 56 |
New York University School of Law
| 3 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 31 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alan L. Fuchsberg
- Personal Network
